APGN
Price:
$0.3851
Market Cap:
$9.57M
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor ce...[Read more]
Industry
Biotechnology
IPO Date
2021-02-22
Stock Exchange
NASDAQ
Ticker
APGN
According to Apexigen, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.23. This represents a change of -65.73% compared to the average of -0.66 of the last 4 quarters.
The mean historical PE Ratio of Apexigen, Inc. over the last ten years is -8.39. The current -0.23 PE Ratio has changed 168.51% with respect to the historical average. Over the past ten years (40 quarters), APGN's PE Ratio was at its highest in in the June 2020 quarter at 0. The PE Ratio was at its lowest in in the September 2020 quarter at -17945.93.
Average
-8.39
Median
-10.77
Minimum
-13.96
Maximum
-0.43
Discovering the peaks and valleys of Apexigen, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.43
Minimum Annual Increase = -96.02%
Minimum Annual PE Ratio = -13.96
Year | PE Ratio | Change |
---|---|---|
2022 | -0.43 | -96.02% |
2021 | -10.77 | -22.85% |
The current PE Ratio of Apexigen, Inc. (APGN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.39
5-year avg
-8.39
10-year avg
-8.39
Apexigen, Inc.’s PE Ratio is greater than Leap Therapeutics, Inc. (-1.83), greater than Ambrx Biopharma Inc. (-25.13), greater than Zura Bio Limited (-9.00), less than X4 Pharmaceuticals, Inc. (7.41), less than Phio Pharmaceuticals Corp. (0), less than eFFECTOR Therapeutics, Inc. (-0.15), less than Immix Biopharma, Inc. (-0.00), greater than Enveric Biosciences, Inc. (-2.98), greater than CohBar, Inc. (-0.36), less than Ocean Biomedical, Inc. (-0.20), less than AVROBIO, Inc. (-0.17), less than null (2.07),
Company | PE Ratio | Market cap |
---|---|---|
-1.83 | $107.52M | |
-25.13 | $1.77B | |
-9.00 | $230.86M | |
7.41 | $109.78M | |
0 | $2.25M | |
-0.15 | $188.18K | |
-0.00 | $54.08M | |
-2.98 | $4.53M | |
-0.36 | $1.25M | |
-0.20 | $33.96M | |
-0.17 | $5.24M | |
2.07 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Apexigen, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Apexigen, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Apexigen, Inc.'s PE Ratio?
How is the PE Ratio calculated for Apexigen, Inc. (APGN)?
What is the highest PE Ratio for Apexigen, Inc. (APGN)?
What is the 3-year average PE Ratio for Apexigen, Inc. (APGN)?
What is the 5-year average PE Ratio for Apexigen, Inc. (APGN)?
How does the current PE Ratio for Apexigen, Inc. (APGN) compare to its historical average?